Skip to main content
Premium Trial:

Request an Annual Quote

EXCLUSIVE: BioBridge Completes PIUMS Project; Partner AstraZeneca Collects First Unit

NEW YORK, Sept. 6 – BioBridge Computing has finished developing its PIUMS protein identification software and has delivered the first unit to its research partner AstraZeneca, GenomeWeb has learned.

PIUMS—or Protein Identification Using Mass Spectrometry—is a fully automated software that includes Pepex, BioBridge’s peak extraction software. The two companies have been developing the software since they first struck a deal in July to develop the product.

A spokesperson for Lund, Sweden-based BioBridge said that the PIUMS software will be launched around November and cost roughly $10,000.

“By developing a new improved scoring algorithm to existing alternatives and a reliable method for validation we have created a very fast database search tool with very high reliability,” said Jim Samuelson, who co-led the project for BioBridge.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.